IL17A and combined immunodeficiency: CID are generally characterized by loss of tolerance for either self-antigens or harmless environmental antigens, resulting in the continuous production of inflammatory mediators, such as interferon-γ by T helper 1 (Th1) cells or interleukin-17 (IL-17) by Th17 cells (1).